Drugs / Fe-ASP
last change Jan 2021 re-read 2 minutes ago

Fe-ASP

Developed for
iron deficiency anemia

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03524651 Comparator May 2018 → Jan 2021 iron deficiency anemia Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Fe-ASP ClinicalTrials.gov intervention name — accepted as the source's own label NCT03524651
Route Oral “new oral formulation of Fe-ASP” NCT03524651